Mass SARS-CoV-2 molecular and serological screening of medical staff and patients in Hangzhou, China: no evidence of RNA detection, low seroprevalence, and limited exposure risk in the hospital setting
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.